LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Generated: 2026-11-02
Case ID: NM_017617.5_c.7541_7542del_20261102_101533
Framework: ACMG/AMP 2015
Variant classification summary

NM_017617.5:c.7541_7542del

NOTCH1  · NP_060087.3:p.(Pro2514ArgfsTer4)  · NM_017617.5
GRCh37: chr9:139390648 CAG>C  ·  GRCh38: chr9:136496196 CAG>C
Gene: NOTCH1 Transcript: NM_017617.5
Final call
VUS
PM2 supporting
All criteria require review: For research and educational purposes only.
Gene
NOTCH1
Transcript
NM_017617.5
Protein
NP_060087.3:p.(Pro2514ArgfsTer4)
gnomAD AF
1.1179471509116859e-05 (v4.1)
ClinVar
Uncertain significance
OncoKB
Likely Oncogenic
Interpretation summary
Generated evidence synthesis
1
PM2 supporting: the variant is extremely rare in gnomAD v4.1, with grpmax FAF 7.64e-06 and zero homozygotes.
Final determination: Generic ACMG/AMP 2015 fallback rules classify the variant as VUS because one supporting criterion alone satisfies none of the pathogenic, likely pathogenic, benign, or likely benign combinations.
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
Criterion Status Rationale Evidence used
PVS1 Not met Not met: the exon 34 frameshift ends at residue 2517 instead of 2556 and removes the PEST degron, producing prolonged NOTCH1 activation rather than a demonstrated null allele.
PMID:25741868 PMID:29998084 pvs1_variant_assessment
PS1 N/A Not applicable: PS1 requires a missense variant, and this is a frameshift variant.
generic_acmg_combination_rules
PS2 Not assessed Not assessed: no documented germline de novo finding with both maternity and paternity confirmed and no family-history information is available.
PMID:30087429 PMID:29998084
PS3 Not assessed Not assessed: exact-variant evidence is limited to sequencing detection, while no validated functional assay result for p.P2514Rfs*4 is available.
PMID:30087429 PMID:29998084 PMID:25564152 PMID:19604236
PS4 Not assessed Not assessed: 2/12 CLL patients carried the exact variant, but no matched unaffected-control cohort supports the required OR >5.0 with a confidence interval excluding 1.0.
PMID:30087429 PMID:29998084 gnomad_v4
PM1 N/A Not applicable: PM1 requires a missense variant, and this is a frameshift variant.
generic_acmg_combination_rules
PM2 Met Met at supporting strength: gnomAD v4.1 grpmax FAF is 7.64e-06, below the supplied PM2 threshold of 0.0001, with zero homozygotes.
gnomad_v2 gnomad_v4 PMID:25741868
PM3 Not assessed Not assessed: no pathogenic allele, recessive inheritance, or parental/offspring phase testing establishes this variant in trans.
PMID:30087429 PMID:29998084
PM4 N/A Not applicable: PM4 requires a protein-length change, and this is a frameshift variant.
pvs1_generic_framework generic_acmg_combination_rules
PM5 N/A Not applicable: PM5 requires a missense variant, and this is a frameshift variant.
generic_acmg_combination_rules
PM6 Not assessed Not assessed: no germline case is documented as assumed de novo without confirmed maternity and paternity.
PMID:30087429 PMID:29998084
PP1 Not assessed Not assessed: no affected relatives, informative meioses, or familial genotype-phenotype cosegregation data are reported.
PMID:30087429 PMID:29998084
PP2 N/A Not applicable: PP2 requires a missense variant, and this is a frameshift variant.
generic_acmg_combination_rules
PP3 N/A Not applicable: the c.7541_7542del frameshift is outside PP3's missense or intronic/synonymous/splice-region computational scope.
PP4 Not met Not met: CLL is genetically heterogeneous, and the available records provide no highly specific patient phenotype or family history for a single-gene disease.
PMID:30087429 PMID:29998084 PMID:22237449
PP5 Not met Not met: ClinVar has zero expert-panel submissions for the exact variant, and all three germline laboratory submissions classify it as uncertain significance.
clinvar PMID:30087429 PMID:29998084
BA1 Not met Not met: gnomAD grpmax FAF is 7.64e-06, far below the 0.05 BA1 threshold, with no qualifying high-frequency population signal.
gnomad_v2 gnomad_v4 PMID:25741868
BS1 Not met Not met: gnomAD v4.1 grpmax FAF is 7.64e-06, below the generic 0.01 BS1 threshold and not evidence of excess disease frequency.
gnomad_v2 gnomad_v4 PMID:25741868
BS2 Not assessed Not assessed: gnomAD shows zero homozygotes, but no phenotype-reviewed healthy adult individual is documented for the BS2 inheritance and penetrance requirements.
gnomad_v2 gnomad_v4
BS3 Not assessed Not assessed: sequencing confirms the exact deletion, but no validated assay demonstrates preserved NOTCH1 function or normal splicing.
PMID:30087429 PMID:29998084 PMID:25564152 PMID:19604236
BS4 Not assessed Not assessed: no informative affected relatives lacking the variant or other familial non-segregation evidence is documented.
PMID:30087429 PMID:29998084
BP1 N/A Not applicable: BP1 requires a missense variant, and this is a frameshift variant.
generic_acmg_combination_rules
BP2 Not assessed Not assessed: no phased pathogenic variant in cis or trans is documented for this germline case.
PMID:30087429 PMID:29998084
BP3 N/A Not applicable: BP3 requires an in-frame indel in a repeat region, and this is a frameshift variant.
pvs1_generic_framework generic_acmg_combination_rules
BP4 N/A Not applicable: BP4 is excluded for this frameshift, regardless of its SpliceAI max delta score of 0.007.
BP5 Not assessed Not assessed: the records do not establish an alternate molecular basis for disease in a case carrying the exact variant.
PMID:30087429 PMID:29998084
BP6 Not met Not met: no exact-variant ClinVar expert-panel submission reports benign or likely benign, while all three laboratory submissions report uncertain significance.
clinvar
BP7 N/A Not applicable: BP7 requires a synonymous variant, and this is a frameshift variant.
generic_acmg_combination_rules
Disclaimer: The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.